“Picking Winners: Portfolio Management for a New Era” White Paper Now Available
Waltham, MA, April 3, 2024—Trinity Life Sciences, a leader in global life sciences commercialization solutions, unveils its Industry Impact Series—a thought leadership series designed to identify key issues that will revolutionize the way therapeutics are developed and commercialized in the years ahead. The first installment of the series, a white paper entitled Picking Winners: Portfolio Management for a New Era, explores the challenges biopharma companies face in selecting…
Read Now
“Annual State of Global Market Access” White Paper Now Available
An Upcoming Webinar Entitled “Annual State of Global Market Access” Will Review Findings
Waltham, MA, March 26, 2024—Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability of its Annual State of Global Market Access white paper, an evaluation of six key global market access trends that life sciences companies need to be monitoring in 2024 and beyond. The paper explores the consequences of new therapeutic…
Read Now
New Chat-based AI Interface Allows Life Sciences Executives to Unlock the Collective Power of All Their Brand Research
Waltham, MA, February 28, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today launched Brand Insights AI to develop, share and refine insights across the full breadth of biopharmaceutical brand research. Designed by experts with deep technical knowledge and expertise in the nuances of life sciences research, it allows insights and analytics teams to answer brand questions…
Read Now
“Trinity Annual Drug Index” White Paper Now Available
An Upcoming Webinar Entitled “Learn From the Past – Launch Better Tomorrow” Will Review Findings
Waltham, MA, February 13, 2024 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, announces the availability of its Trinity Annual Drug Index white paper, an evaluation of the commercial performances over three years of 58 novel drugs approved in 2020. An upcoming webinar Learn From the Past – Launch Better Tomorrow will help…
Read Now
New White Paper “2022 NRDL Pricing Implementation and Access Outcomes in China” Available Now from Trinity Life Sciences
Waltham, MA, December 20, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, reports that China’s 2022 National Reimbursement Drug List (NRDL) demonstrates promising pricing and access opportunities for innovative drugs with significant clinical benefit. The new white paper “2022 NRDL Pricing Implementation and Access Outcomes in China” provides an in-depth analysis and key takeaways of the update.…
Read Now
COE Provides Deep Strategic Expertise and Analytical Capabilities to Support Cell and Gene Therapy Organizations Across the Value Chain
New White Paper “Empowering Cancer Immunotherapy: Unleashing the Potential of NK Cell Therapies in Oncology” Delivers Overarching Assessment of the Natural Killer Cell Therapy Space
Waltham, MA, December 18, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, introduces a Cell & Gene Therapy (C>) Center of Excellence (COE) that supports life sciences companies in successfully commercializing…
Read Now
Waltham, MA, December 13, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, has made available its TGaS Advisors’ brief “What You Need To Know Now To Be Prepared for 2024” based on highlights presented at the TGaS Advisors’ 2023 Fall Client Summit. The TGaS 2023 Fall Client Summit included 16 function-specific sessions in the areas of commercial operations, market access and medical affairs. The sessions were held virtually in October and November with over 500…
Read Now
Waltham, MA, November 29, 2023 – Trinity Life Sciences, a leader in global life sciences commercialization solutions, released its third annual TGaS Digital Marketing Competency Report assessing 160+ biopharma brands through the lens of digital marketing patient/caregiver experiences. The study evaluates the brands across five categories and more than 100 characteristics to understand each one’s digital marketing presence and establish a brand digital competency ranking.
Brands that topped the 2023 Digital Marketing Competency Report’s list include:
Pfizer’s Nurtec
Idorsia’s Quviviq…
Read Now
New Advisory Brief Discusses Four Pillars to Focus Resource Allocation, Improve Patient Care and Provide Differentiated Patient Partnership
Waltham, MA, November 20, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, maps out investment strategies and tactics to calibrate a patient-centric approach in rare disease in its new advisory brief. The brief outlines four pillars that focus resource allocation, improve patient care and provide differentiated patient partnership. Within the nuances of each disease, companies must effectively…
Read Now
Rajeev Rangachari Plans to Bolster a Culture of Innovation
Waltham, MA, October 23, 2023 — Trinity Life Sciences, a leader in global life sciences commercialization solutions, today announced the appointment of Rajeev Rangachari to serve as the Company’s first-ever Chief Technology Officer (CTO). Mr. Rangachari brings significant experience in building flexible, scalable solutions for life sciences organizations to Trinity.
As CTO, Mr. Rangachari will infuse technology into every aspect of Trinity’s offerings and workflow, accelerating business processes with technology assets.…
Read Now
